Study: Alzheimer's drug safe, effective Alzheimer's Drug Study The U.S.Food and Drug Association approved memantine HCl to treat moderate to severe Alzheimer's disease in October 2003.
The study in the January issue of the Archives of Neurology finds that the drug is...
Forest Laboratories Inc. F4Q09 (Qtr End 6/30/08) Earnings Call Transcript Frank Perier, Jr - SVP, Finance and CFO Larry Olanoff - President and COO Analysts Rich Silver - Lehman Brothers Greg Gilbert - Merrill Lynch Frank Pinkerton - Banc of America Securities Corey Davis - Natixis Bleichroeder Annabel Samimy --...
Forest earnings hurt by charges but Lexapro sales keep rising US drugmaker Forest Laboratories has posted a 4.2% increase in fiscal first-quarter revenues to $966.8 million, helped by another strong performance from its flagship antidepressant Lexapro, though earnings suffered as a result of charges.
Forest Labs quarterly profit beats estimates NEW YORK (Reuters) - Forest Laboratories Inc reported a 9 percent decline in quarterly profit on Tuesday on higher sales and administrative costs, but results were better than expected and the company forecast fiscal-year earnings ahead of...
Forest Gets Boost From Lexapro, Namenda 8 Stocks for Fans of Takeover Targets 8 Stocks for Fans of Takeover Targets 8 Stocks for Fans of Takeover Targets 8 Stocks for Fans of Takeover Targets 8 Stocks for Fans of Takeover Targets 8 Stocks for Fans of Takeover Targets 8 Stocks for...
Alzheimer's Research Brings Progress, Setbacks FRIDAY, July 18 (HealthDay News) -- It's one step forward, one step back in the search for treatments against Alzheimer's disease.In one of two studies in the July 19 issue of The Lancet, an older drug called dimebon significantly...
Alzheimer's Research Brings Progress, Setbacks FRIDAY, July 18 (HealthDay News) -- It's one step forward, one step back in the search for treatments against Alzheimer's disease.In one of two studies in the July 19 issue of The Lancet, an older drug called dimebon significantly...
Alzheimer's Research Brings Progress, Setbacks FRIDAY, July 18 (HealthDay News) -- It's one step forward, one step back in the search for treatments against Alzheimer's disease.In one of two studies in the July 19 issue of The Lancet, an older drug called dimebon significantly...
Studies show mixed success in Alzheimer's fight CHICAGO (Reuters) - A new drug showed promise at treating Alzheimer's disease, but an experimental vaccine that cleared brain-clogging plaques failed to improve memory or help patients live longer, researchers said on Thursday.One of two...
Alzheimer's Research Brings Progress, Setbacks FRIDAY, July 18 (HealthDay News) -- It's one step forward, one step back in the search for treatments against Alzheimer's disease.In one of two studies in the July 19 issue of The Lancet, an older drug called dimebon significantly...
Alzheimer's Research Brings Progress, Setbacks Once-promising vaccine fails to ease symptoms, but old drug offers new hope FRIDAY, July 18 (HealthDay News) -- It's one step forward, one step back in the search for treatments against Alzheimer's disease.In one of two studies in the...
Alzheimer's Research Brings Progress, Setbacks FRIDAY, July 18 (HealthDay News) -- It's one step forward, one step back in the search for treatments against Alzheimer's disease.In one of two studies in the July 19 issue of The Lancet, an older drug called dimebon significantly...
WOC symposium: Neuroprotection as possible wave of the future in glaucoma therapy Ophthalmology Times Meeting E-News Do pressure-independent factors play a role in glaucoma?That would seem to be the case, since the disease progresses in many patients despite IOP reduction?
Enter a new line of thinking about the...
Neuroprotection as possible wave of the future in glaucoma therapy Ophthalmology Times Meeting E-News Do pressure-independent factors play a role in glaucoma?That would seem to be the case, since the disease progresses in many patients despite IOP reduction?
Enter a new line of thinking about the...
Alzheimer's Drug May Prevent Brain Damage in Preemies Researchers have discovered that a drug marketed to slow the progression of memory loss in Alzheimer's disease may also prevent brain damage in as many as 35 percent of premature infants.Scientists at Children's Hospital Boston in a study...
Alzheimer's Drug May Help Preemies Namenda May Help Prevent Brain Damage in Premature Infants June 24, 2008 A drug used to treat older patients with Alzheimer's disease may help protect the youngest premature infants from harm.A new study suggests that Namenda, ...
Alzheimer's Drug May Reduce Preemie Brain Injury Memantine could protect newborns with compromised blood, oxygen supply, study suggests TUESDAY, June 24 (HealthDay News) -- The Alzheimer's drug memantine (brand name Namenda) may help reduce a form of brain injury that affects many...
Alzheimer's Drug May Help Preemies Namenda May Help Prevent Brain Damage in Premature Infants WebMD Medical News Reviewed By Louise Chang, MD June 24, 2008 A drug used to treat older patients with Alzheimer's disease may help protect the youngest premature infants from...
Alzheimer€™s Drug May Help Preemies -- A drug used to treat older patients with Alzheimer's disease may help protect the youngest premature infants from harm.A new study suggests that Namenda, a drug originally developed to treat Alzheimer's disease, may help break...
Alzheimer's Drug May Help Preemies -- A drug used to treat older patients with Alzheimer's disease may help protect the youngest premature infants from harm.A new study suggests that Namenda, a drug originally developed to treat Alzheimer's disease, may help break...
Alzheimer's Drug May Reduce Preemie Brain Injury TUESDAY, June 24 (HealthDay News) -- The Alzheimer's drug memantine (brand name Namenda) may help reduce a form of brain injury that affects many premature babies, according to a Children's Hospital Boston study.Hypoxic-ischemia, a...
Alzheimer's Drug May Reduce Preemie Brain Injury TUESDAY, June 24 (HealthDay News) -- The Alzheimer's drug memantine (brand name Namenda) may help reduce a form of brain injury that affects many premature babies, according to a Children's Hospital Boston study.Hypoxic-ischemia, a...
Alzheimer's Drug May Reduce Preemie Brain Injury TUESDAY, June 24 (HealthDay News) -- The Alzheimer's drug memantine (brand name Namenda) may help reduce a form of brain injury that affects many premature babies, according to a Children's Hospital Boston study.Hypoxic-ischemia, a...
Alzheimer's Drug May Reduce Preemie Brain Injury TUESDAY, June 24 (HealthDay News) -- The Alzheimer's drug memantine (brand name Namenda) may help reduce a form of brain injury that affects many premature babies, according to a Children's Hospital Boston study.Hypoxic-ischemia, a...
Alzheimer's Drug May Reduce Preemie Brain Injury TUESDAY, June 24 (HealthDay News) -- The Alzheimer's drug memantine (brand name Namenda) may help reduce a form of brain injury that affects many premature babies, according to a Children's Hospital Boston study.Hypoxic-ischemia, a...
